SynthesisCritical reviews in clinical laboratory sciences2024

KIF2C/MCAK a prognostic biomarker and its oncogenic potential in malignant progression, and prognosis of cancer patients: a systematic review and meta-analysis as biomarker.

Nina-Naomi Kreis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.